News from the European Society of Cardiology Conference (FREE)

By the Editors Here's a quick look at some of the major news that came out of the European Society of Cardiology Congress in London this weekend:Cyclosporine Before Percutaneous Coronary Intervention? Among patients with acute anterior …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news

Related Links:

Abiomed said it has received approval for an IDE to start an early feasibility study of what it is calling the “world’s smallest heart pump.”   The Danvers, MA-based company said the first-in-human trial will look at the 9 French Impella ECP heart pump in high-risk percutaneous coronary intervention (PCI) patients.   The primary endpoint of the study is successful delivery, initiation, and maintenance of adequate hemodynamic support and a composite rate of major device-related adverse events during high-risk PCI.   The stu...
Source: MDDI - Category: Medical Devices Tags: Cardiovascular Regulatory and Compliance Source Type: news
The clinical outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) in prior coronary artery bypass graft (pCABG) patients have been investigated; however, the results are inconsistent. The present meta-analysis compared the clinical outcomes of CTO PCI in patients with and without prior CABG (nCABG). The endpoints included technical success, procedural success, all-cause mortality, myocardial infarction (MI), major bleeding, coronary perforation, pericardial tamponade, emergency CABG, and vascular access complication. A total of 7 studies comprising of 11099 patients were included in this met...
Source: Medicine - Category: Internal Medicine Tags: Research Article: Meta-Analysis of Observational Studies in Epidemiology Source Type: research
Tirofiban is widely used in patients with acute ST elevation myocardial infarction (STEMI) underwent percutaneous coronary intervention (PCI). This drug can efficiently improve myocardial perfusion and cardiac function, but its dose still remains controversial. We here investigated the effects of different dose of tirofiban on myocardial reperfusion and heart function in patients with STEMI. A total of 312 STEMI patients who underwent PCI in our hospital from March 2017 to March 2018 were enrolled and randomly divided into control group (75 cases, 0 μg/kg), low-dose group (79 cases, 5 μg/kg), medium-dose group (8...
Source: Medicine - Category: Internal Medicine Tags: Research Article: Observational Study Source Type: research
We report DI–DO times and identify the main factors affecting them. RESURCOR is a French Northern Alps registry of patients with STEMI of
Source: Medicine - Category: Internal Medicine Tags: Research Article: Observational Study Source Type: research
This article provides a review of the current clinical evidence concerning the Firehawk stent.
Source: Cardiology in Review - Category: Cardiology Tags: New Therapy Update Source Type: research
To determine, in patients with acute coronary syndromes (ACS) or undergoing percutaneous coronary intervention (PCI), the effectiveness and safety between personalized P2Y12 inhibitors treatment based on genotypes and standard treatment.
Source: Thrombosis Research - Category: Hematology Authors: Tags: Review Article Source Type: research
Authors: Xia W, Yang N, Li Y Abstract BACKGROUND The present research aimed to explore the risk factors for adverse cardiovascular events in elderly patients with acute myocardial infarction (AMI) combined with NAFLD. MATERIAL AND METHODS We included 325 AMI patients hospitalized in the Department of Cardiology. AMI patients underwent emergency thrombolysis or percutaneous coronary intervention (PCI). AMI patients were classified into NAFLD group and non-NAFLD group. General clinical data, creatinine and myocardial enzyme, GRACE scores of AMI patients were evaluated and compared between two groups. Incidence of adv...
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
Authors: Yeo KK, Azarbal F, Zakroysky P, Dai D, Roe M, Wojdyla D, Low R, Shunk K Abstract OBJECTIVES: Limited studies of percutaneous coronary intervention (PCI) of the left internal mammary artery (LIMA) graft exist. We compared outcomes of different bypass grafts to the left anterior descending (LAD) coronary artery. METHODS: Participants ≥65 years old in the CathPCI Registry who underwent PCI of a bypass graft to the LAD between 2009 and 2014 were included. Individuals were divided by graft type: LIMA; saphenous vein graft (SVG); or other. Clinical characteristics and outcomes using Medicare claims data f...
Source: The Journal of Invasive Cardiology - Category: Cardiology Tags: J Invasive Cardiol Source Type: research
To mitigate the risk of stent thrombosis, patients treated by percutaneous coronary intervention (PCI) are administered dual anti-platelet therapy comprising aspirin and a platelet P2Y12 receptor inhibitor. Clopi...
Source: BMC Cardiovascular Disorders - Category: Cardiology Authors: Tags: Study protocol Source Type: research
Atherosclerosis is associated with chronic inflammation and lipid metabolism. The neutrophil to lymphocyte ratio (NLR) as an indicator of inflammation has been confirmed to be associated with cardiovascular di...
Source: Lipids in Health and Disease - Category: Lipidology Authors: Tags: Research Source Type: research
More News: Angioplasty | Cardiology | Conferences | Coronary Angioplasty | Heart | Percutaneous Coronary Intervention | Politics | Primary Care | Restasis